Streetbeat News

Analyst Ratings

VECT

Over the past 3 months, 4 analysts have published their opinion on VectivBio Holding (NASDAQ:VECT) stock, with an average price target of $19.0, implying upside from the current price of $16.5. The current average has decreased by 24.0% from the previous average price target of $25.00.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 9:02 pm

WSO

Over the past 3 months, 10 analysts have published their opinions on Watsco (NYSE:WSO) stock, with an average 12-month price target of $341.1, a high of $400, and a low of $269. The average price target has increased by 8.53% over the past month.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 9:02 pm

CBRE

CBRE Group (NYSE:CBRE) has received 4 bullish and 2 indifferent analyst ratings in the last quarter, with an average price target of $86.67, down 6.47% from the previous target of $92.67. The current price of CBRE Group is $76.14.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 9:02 pm

AJG

In the last quarter, Arthur J. Gallagher (NYSE:AJG) received 5 bullish, 2 somewhat bullish, and 2 indifferent analyst ratings. The average price target is $230.56, representing an upside from the current price of $206.64.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 9:01 pm

SNDR

In the last 3 months, 4 analysts have provided 12-month price targets for Schneider National (NYSE:SNDR), with an average price target of $32.25, down 8.72% from the previous average of $35.33.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 9:01 pm

ESRT

Over the past 3 months, 6 analysts have published their opinion on Empire State Realty Trust (NYSE:ESRT) stock, with an average price target of $7.58, implying an upside from the current price of $6.52. The current average has increased by 4.55% from the previous average price target of $7.25.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 9:00 pm

BIIB

In the last quarter, Biogen (NASDAQ:BIIB) received 9 bullish, 5 somewhat bullish, and 7 indifferent analyst ratings. The average 12-month price target for the company is $318.81, with a high of $371.00 and a low of $263.00. The average price target has increased by 3.17% over the past month.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 8:03 pm

STOK

In the last 3 months, 12 analysts have provided 12-month price targets for Stoke Therapeutics (NASDAQ:STOK), with an average price target of $25.17, up 7.11% from the previous average of $23.50. The ratings include 6 bullish, 5 somewhat bullish, and 1 indifferent.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 8:03 pm

WERN

Over the past 3 months, 7 analysts have published their opinion on Werner Enterprises (NASDAQ:WERN) stock, with an average 12-month price target of $52.71. The current average has decreased by 2.39% from the previous average price target of $54.00.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 8:02 pm

MELI

Unusual options activity has been observed in MercadoLibre (NASDAQ:MELI), with a bearish stance taken by a whale. 73% of the investors have bearish expectations, with 7 puts totaling $957,265 and 12 calls totaling $609,065. Whales have targeted a price range of $800 to $2000 for MercadoLibre over the last 3 months. Major banks maintain positive ratings on the stock.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 8:02 pm